Ethic Inc’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
+17,444
New +$249K ﹤0.01% 1276
2025
Q2
Sell
-10,588
Closed -$159K 1231
2025
Q1
$159K Sell
10,588
-3,863
-27% -$64.7K ﹤0.01% 1089
2024
Q4
$250K Buy
14,451
+4,389
+44% +$84.7K 0.01% 985
2024
Q3
$172K Sell
10,062
-4,084
-29% -$82K ﹤0.01% 1017
2024
Q2
$287K Buy
14,146
+4,084
+41% +$72.3K 0.01% 923
2024
Q1
$172K Buy
+10,062
New +$158K ﹤0.01% 1016

Other funds holding CLB

Ethic Inc's CLB Position: Q2 2026 in Review

Ethic Inc opened a new position in Core Laboratories (CLB) in Q2 2026: 17,444 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Ethic Inc previously reported a position in CLB as recently as Q1 2025.

Ethic Inc first reported a position in CLB in Q1 2024 and has held it in 6 quarters since. The position peaked at $287K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Ethic Inc held 17,444 shares of Core Laboratories worth $203K as of Q2 2026.
  • Core Laboratories was a new Ethic Inc position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1276 holding.
  • Ethic Inc first reported a position in Core Laboratories in Q1 2024 and has held it in 6 quarters since.
  • Ethic Inc's Core Laboratories position peaked at $287K in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.